15 Small-Cap Stocks with High Potential
In this article, we will take a look at the 15 small-cap stocks with high potential.
Olema Pharmaceuticals Inc. (OLMA)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Biotechnology Value Fund / BVF Inc Mark Lampert | 9,135,893 | $109,082,562 | 3.19% | |
| 2. | Deep Track Capital David Kroin | 4,000,000 | $47,760,000 | 1.51% | |
| 3. | Point72 Asset Management Steve Cohen | 3,687,374 | $44,027,246 | +15% | 0.11% |
| 4. | Logos Capital Arsani William | 3,208,875 | $38,313,968 | 4.13% | |
| 5. | BioImpact Capital Mpm Capital | 2,680,596 | $32,006,316 | +1% | 4.8% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $6.75 | 700,761 | Director | 700,761 | 2024-12-13 | Filing | |
| $6.75 | 700,761 | Director | 1,408,875 | 2024-12-17 | Filing | |
| $13.09 | 50,000 | Director | 1,800,000 | 2023-12-05 | Filing | |
| $14.95 | 50,000 | Director | 1,750,000 | 2023-12-05 | Filing | |
| $14.73 | 31,870 | Director | 1,700,000 | 2023-12-05 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $6.75 | 700,761 | Director | 0 | 2024-12-13 | Filing | |
| $6.75 | 700,761 | Director | 0 | 2024-12-17 | Filing | |
| $9.39 | 179 | 764,140 | 2024-12-11 | Filing | ||
| $8.66 | 7,958 | 764,319 | 2024-12-11 | Filing | ||
| $9.37 | 8,256 | 772,277 | 2024-12-10 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 7,903,600 | $110,887,508 | 5.19% | |
| 2. | 3,263,907 | $45,792,615 | 0% | |
| 3. | 2,705,895 | $37,963,707 | 0% | |
| 4. | 1,715,420 | $24,068,813 | 0% | |
| 5. | 824,833 | $11,574,367 | 0% |
News See All
12 Best Performing NASDAQ Stocks in 2023
In this piece, we will take a look at the 12 best performing NASDAQ stocks in 2023.
5 Best Performing Biotech Stocks in 2023
In this piece, we will take a look at the five best performing biotechnology stocks in 2023.
8 Stocks in Eashwar Krishnan's Tybourne Capital Management Portfolio
In this article, we will take a look at some of the stocks in Eashwar Krishnan’s Tybourne Capital Management portfolio.
5 Best Biotech Stocks to Buy According to Mark Lampert's Biotechnology Value Fund
In this article, we discuss the 5 best biotech stocks to buy according to Mark Lampert.
5 Pharma Stocks to Buy According to Mark Lampert’s Biotechnology Value Fund
Below is the list of 5 pharma stocks to buy according to Mark Lampert’s Biotechnology Value Fund.
Hedge Fund and Insider Trading News: York Capital Management, Point72 Asset Management, Elliott Advisors, Cresco Labs Inc (CRLBF), Estee Lauder Companies Inc (EL), and More
Blackstart Capital, which listed $319 million under management on a recent disclosure form, has terminated its registration with the Securities and Exchange Commission.
Billionaire Hedge Funds
